Clinical benefit and fragility evaluation of systemic therapy trials for advanced soft tissue sarcoma
Sign Up to like & getrecommendations! Published in 2024 at "Cancer"
DOI: 10.1002/cncr.35564
Abstract: The clinical benefit of systemic anticancer therapies can be unclear despite positive trials, and outcomes may not translate to real‐world practice. This study evaluated the benefit of soft tissue sarcoma (STS) treatments using the European… read more here.
Keywords: tissue sarcoma; benefit; clinical benefit; benefit fragility ... See more keywords